Six crossbred steers (261 ± 18 kg BW) fitted with hepatic portal, mesenteric venous and arterial catheters, and duodenal, midjejunal, and ileal cannulas were used in a replicated 3 × 3 Latin square design to determine the effect of varying levels and site of glucose plus 2-deoxyglucose (2DG) infusion on net portal-drained visceral flux. Steers were fed chopped alfalfa in six equal portions daily at 1.5% of BW. Glucose (0, 9, or 18 g/h) and 2DG (0, 1, or 2 g/h) were infused continuously through the duodenal or midjejunal cannula (two infusion sites) at total glucose plus 2DG infusion rates of 0, 10, or 20 g/h. Arterial and portal blood samples were taken simultaneously at 20-min intervals from 5 to 9 h of infusion. Portal blood flow was determined by continuous infusion of p-aminohippurate and net flux was calculated as venous-arterial concentration (PA) difference times blood flow. Arterial concentration of glucose was not affected ( P > .10) by glucose plus 2DG infusion, whereas arterial concentration of 2DG was greater ( P < .05) when glucose plus 2DG was infused into the duodenum and increased (linear, P < .10) as amount of glucose plus 2DG infused into both the duodenum and midjejunum increased. Net portal flux and PA difference of glucose and 2DG were greater ( P < .05) when glucose plus 2DG was infused into the duodenum. Although 2DG was infused at 10% of the total glucose plus 2DG infusion, it accounted for only 1.7 and .7% of the glucose plus 2DG appearing in portal blood when glucose plus 2DG was infused at 10 and 20 g/h, respectively. We conclude that glucose is more readily absorbed across the proximal-half than the distal-half of the small intestine, and that passive diffusion is a minor route of glucose absorption.
Introduction
Feeding grain-based diets to ruminants has increased with intensification of animal production systems. Therefore, understanding small intestinal starch digestion and subsequent glucose absorption has increased in importance. Mayes and Ørskov (1974) indicated that production of glucose by starch hydrolysis occurs at a faster rate than active transport of glucose across the small intestine. This phenomenon, coupled with estimates of only 26 to 57% net portal glucose absorption when starch is infused abomasally (Huntington and Reynolds, 1986; Kreikemeier et al., 1991; Kreikemeier and Harmon, 1995) , may indicate that small intestinal starch digestion occurs at a site that is not optimal for glucose absorption.
Small intestinal glucose absorption in ruminants is hypothesized to occur by both active transport and passive diffusion (White et al., 1971; Kreikemeier et al., 1991) . Active transport of glucose has been shown to occur by the Na + -dependent glucose cotransporter ( SGLT1; Hopfer, 1987; Shirazi-Beechey et al., 1991) . However, passive diffusion of glucose across the small intestine has not been directly demonstrated in vivo. Two-deoxyglucose, a non-metabolizable sugar, is not transported by SGLT1 (Hopfer, 1987; Wright et al., 1994) . Therefore, its absorption most likely occurs only via passive diffusion.
The objectives of this experiment were to determine whether glucose is more readily absorbed across the proximal-or distal-half of the small intestine and to determine whether passive diffusion of glucose occurs in the small intestine in steers.
Materials and Methods
Experimental. Six crossbred steers (BW = 261 ± 18 kg at the beginning of the experiment) were surgically fitted with chronic indwelling catheters in the hepatic portal vein, two mesenteric veins, and a mesenteric artery (Huntington et al., 1989) . Catheter patency was maintained by filling catheters with a heparinized-saline solution (1,000 U/mL) between sampling periods. The right carotid artery was elevated (McDowell et al., 1966) to provide access to arterial blood in the case of a nonpatent mesenteric arterial catheter. In addition, infusion cannulas (3.2 mm i.d. × 4.8 mm o.d. × 183 cm Tygon tubing; Norton Co., Akron, OH) were implanted into the duodenum and midjejunum and a double L-shaped ileal cannula (Streeter et al., 1991) was placed 60 to 90 cm anterior to the ileo-cecal junction. The midjejunum was located during surgery by measuring the length of the small intestine, with sterilized string, from the pyloric valve to the ileo-cecal junction and inserting the infusion cannula at the half-way site. Patency of the duodenal and midjejunal infusion cannulas was maintained by filling them with mineral oil between infusion periods. All surgical procedures and postsurgical care had been previously reviewed and approved by the University of Nebraska Institutional Animal Care and Use Committee. Surgery was conducted aseptically under general anesthesia using halothane.
Steers were allowed a 1-mo recovery period after surgery. During recovery, steers were adapted to a chopped alfalfa hay (17% CP) diet fed at 1.5% of BW (DM basis) in six equal portions daily by an automatic feeding system. This diet of alfalfa hay provided their daily maintenance requirement (NRC, 1984) , and was chosen to minimize the amount of starch flowing to the small intestine from the diet. All steers had ad libitum access to fresh water and a trace mineralized salt block (not less than 95% NaCl, .35% Zn, .28% Mn, .175% Fe, .035% Cu, .007% I, and .007% Co). Steers were housed in a confined temperaturecontrolled (25°C ) environment and tethered in tie stalls ( 2 m × 3 m ) on rubber mats.
Steers were randomly allotted to a replicated 3 × 3 Latin square design balanced for residual effects (Cochran and Cox, 1957) . Glucose (0, 9, or 18 g/h) and 2-deoxyglucose ( 2DG; 0, 1, or 2 g/h) were infused for 9 h for a total glucose plus 2DG infusion rate of 0, 10, or 20 g/h. We chose these levels of glucose infusion to minimize appearance of glucose at the ileum (Kreikemeier et al., 1991) . These solutions were infused into the duodenum or midjejunum, which represented two infusion sites. One replicate (three steers) was infused duodenally with glucose plus 2DG and sampled on d 1, and the remaining three steers were infused duodenally and sampled on d 2 of each period. On d 4 of each period, steers infused on d 1 were infused midjejunally with glucose plus 2DG and sampled. On d 5 of each period, steers infused on d 2 were infused midjejunally and sampled. One period was completed each week with 2 d between duodenal and midjejunal infusions, and 3 d between each period. The infusion solutions consisted of the appropriate amount of glucose, 2DG, and 5% CrEDTA (wt/vol; Binnerts et al., 1968) , which was used as an ileal fluid flow marker. Each solution was diluted with water to a total of 2,250 mL for the 9-h infusion. A multi-channel flow inducer (Model 501sr/50, WatsonMarlow, Falmouth, Cornwall, U.K.) was used to infuse the solutions into the duodenum or midjejunum. Portal blood and plasma flows were measured by the downstream dilution of a primed (15 mL) continuous infusion (.70 mL/min) of p-aminohippurate ( PAH; 10% wt/vol, pH 7.4) infused through a sterile .45-mm filter.
Sampling. Simultaneous arterial and portal blood samples were taken six times at 0, 1, 2, 3, 4, and 5 h of the duodenal-or midjejunal-infusion period to determine the acute effect of glucose plus 2DG infusion on net PDV flux of glucose and insulin. Seven milliliters of arterial or portal blood were collected slowly into syringes beginning 1 h after the priming dose of PAH, transferred to 13-× 100-mm centrifuge tubes containing 100 I.U. of heparin, and immediately placed on ice. These samples were immediately transported to the laboratory, centrifuged (15,000 × g, 15 min at 4°C), and plasma was harvested and frozen ( −70°C). An additional 1 mL of whole blood was collected, mixed with 2 mL of H 2 O containing heparin (20 U/mL), and analyzed for PAH (Harvey and Brothers, 1962) and glucose (Gochmann and Schmitz, 1972 ) using a Technicon Autoanalyzer System (Technicon Autoanalyzer Systems, Tarrytown, NY).
It was assumed that steady-state conditions occurred by 5 h of glucose plus 2DG infusion (Kreikemeier et al., 1991) . Therefore, an additional 12 samples were taken at 20-min intervals from 5 to 9 h of duodenal or midjejunal infusion for determination of PDV flux of glucose, 2DG, a-amino N ( AAN) , Llactate, and oxygen. Twelve milliliters of arterial or portal blood was collected slowly into heparinized syringes. One milliliter of whole blood was analyzed immediately for hemoglobin and O 2 saturation using a Hemoximeter (Radiometer America, Westlake, OH) and packed cell volume ( PCV) . The Hemoximeter was calibrated for both hemoglobin and O 2 saturation as specified by Burrin et al. (1989) . Packed cell volume was measured by drawing whole blood into microhematocrit capillary tubes and centrifuging (15,000 × g, 5 min). An additional 1 mL of blood was mixed with 2 mL of H 2 O containing heparin (20 U/ mL) for analysis of PAH and glucose as described above. Seven milliliters of blood was centrifuged (15,000 × g, 15 min at 4°C), and plasma was harvested and then frozen ( −20°C). One and one-half milliliters of blood from each of the 12 samples was composited (18 mL) within sampling site and then frozen ( −20°C). An additional 1.5 mL of blood from each of the 12 samples was composited (18 mL) within site and deproteinized by adding 1.8 mL of 6 N HClO 4 , mixing and centrifuging. Ten milliliters of supernatant fluid was made alkaline by adding .91 mL of 6 N KOH; the mixture was centrifuged, and the supernatant was decanted and frozen ( −20°C) . From 5 to 9 h of infusion, five samples of ileal contents were collected (100 to 200 g/sample) at 1-h intervals. Ileal pH was recorded, and 10 M NaOH solution was added (100 mL digesta: .5 mL NaOH) to raise the pH from neutral to greater than 10 to inactivate any residual carbohydrase activity in the digesta. The samples were then frozen ( −20°C ) for later analyses.
Arterial and portal plasma samples were assayed for AAN (Palmer and Peters, 1969) and PAH using standards prepared from the infusion solutions. LLactate (Gutmann and Wahlefeld, 1974) and 2DG were analyzed using composited, deproteinized, whole blood that had been frozen ( −20°C). Concentrations of 2DG were determined using anion exchange chromatography followed by pulsed amperometric detection as described by Hardy et al. (1988) . Insulin was quantified (Kasser et al., 1981) in plasma that had been frozen ( −70°C ) by a double-antibody radioimmunoassay, using bovine insulin as reference standard (Lilly Research Laboratories, Indianapolis, IN), guinea pig anti-insulin primary antibody (Miles Laboratories, Elkhart, IN), and goat anti-guinea pig gamma globulin (Antibody, Inc., Davis, CA) as second antibody.
Ileal digesta was analyzed for DM by drying in a forced-air oven (48 h at 65°C). A portion of ileal digesta was centrifuged at 15,000 × g for 10 min and the supernatant fluid saved. The supernatant fraction was analyzed for Cr by atomic absorption spectroscopy and for glucose as described previously, and a portion was combined with 25% (wt/vol) metaphosphoric acid ( 4 parts supernatant: 1 part metaphosphoric acid) for VFA analysis (Harmon et al., 1985) .
Calculations. Ileal fluid flow was determined by dividing the abomasal Cr infusion rate by ileal fluid Cr concentration. Ileal fluid samples containing no Cr were excluded from the statistical analysis. Digesta flow at the ileum was calculated as previously described by Kreikemeier and Harmon (1995) , and net flux of nutrients across the PDV vascular bed was calculated as previously described by Krehbiel et al. (1992) . A positive net flux indicates a release or net absorption of glucose, whereas a negative net flux implies net uptake or utilization by gastrointestinal tissues. Blood flow calculated for each sample from 0 to 5 h of infusion was multiplied by portal-arterial concentration ( PA) difference data for each hour to calculate net flux of glucose and insulin.
Statistics. Data were analyzed as a replicated Latin square design using the GLM procedure of SAS (1989) . Data collected from the 0-through 5-h sampling times were analyzed as a split-split-plot. The whole plot variables were steer, period, and level of glucose plus 2DG infusion, the subplot variable was infusion site (duodenum vs midjejunum), and the sub-subplot variable was time. Sums of squares due to period × level × animal(square) were used as the whole-plot error term to test for level of glucose plus 2DG effects, and sums of squares due to period × level × site × animal(square) were used to test for site and site × level effects. The residual sums of squares were used to test for the significance of time and the interactions of time × level, time × site, and time × level × site. Data collected from 5 to 9 h of glucose plus 2DG infusion were analyzed as a split-plot. Arithmetic means were generated for each steer within each sampling period by averaging all values obtained from each blood sample and those ileal samples containing Cr. The model included square, steer within square, period, and infusion level, which were tested with the between-subject residual error term, and the effect of site of infusion and its interaction with infusion level, which were tested with the within-subject residual error term. Sums of squares due to infusion level were further partitioned into linear and quadratic effects of glucose plus 2DG infusion level. Results were considered significant at the P < .10 level.
Results
One midjejunal catheter plugged before the initiation of the experiment. Therefore, least squares means for the midjejunal infusion data represent five animals per treatment, whereas means for the duodenal infusion data represent six animals per treatment. After the experiment, steers were euthanatized with sodium pentobarbital (10 mL/45.4 kg of BW) and infusion cannula placement was evaluated. The midjejunal cannulas were placed an average of 14.3 ± 2.2 m from the pyloric valve, and the length of the small intestine averaged 23.2 ± 2.4 m. Therefore, the cannulas were skewed distally from the center point of the small intestine toward the ileum.
From 0 to 5 h, arterial glucose concentration was not affected ( P > .10) by increasing glucose plus 2DG infusion from 0 to 20 g/h (data not shown). However, PA difference and net PDV flux of glucose were greater (site effect, P < .05) when total glucose was infused in the duodenum and increased (level effect, P < .10) as glucose plus 2DG infusion increased.
Arterial insulin concentration increased ( P < .05) from 0 to 5 h of glucose plus 2DG infusion (data not shown). Arterial insulin concentration also responded with a site × level interaction ( P < .01). When increasing glucose plus 2DG was infused into the duodenum, arterial insulin concentration increased. Table 2 . Effects of increasing duodenal or midjejunal glucose plus 2-deoxyglucose infusion from 5 to 9 hours on net portal glucose flux and small intestinal disappearance a Standard error of the mean, n = 6 for duodenum, n = 5 for midjejunum. b Site × level effect ( P < .01). c Calculated as: glucose infused − (ileal glucose flow − ileal glucose flow when water was infused Conversely, when glucose plus 2DG was infused into the midjejunum no increase in arterial insulin concentration was observed. In addition, portal minus arterial concentration difference and net PDV flux of insulin were greater (site effect, P < .05) when glucose plus 2DG was infused into the duodenum than when infused into the midjejunum. There was no effect ( P > .10) of glucose plus 2DG infusion on digesta characteristics at the ileum (Table  1) . Dry matter content and pH of ileal fluid were lower ( P < .10) when glucose plus 2DG was infused into the midjejunum than when glucose plus 2DG was infused into the duodenum. Dry matter and total digesta flow past the ileum were not affected ( P > .10) by site of glucose plus 2DG infused, whereas ileal fluid flow was greater ( P < .10) when glucose plus 2DG was infused into the midjejunum. The greater ileal fluid flow when glucose plus 2DG was infused into the midjejunum may be the result of increased osmotic pull associated with higher levels of glucose in ileal fluid (Table 2) . Ileal acetate and total VFA concentrations were greater ( P < .05) when glucose plus 2DG was infused into the duodenum than when glucose plus 2DG was infused into the midjejunum, although total VFA flow was not affected ( P > .10) by site of glucose plus 2DG infusion (Table 1) .
Concentration of glucose in ileal fluid and ileal glucose flow responded with a site × level interaction ( P < .01; Table 2 ). Ileal glucose concentration and flow were lower when glucose plus 2DG was infused Table 3 . Influence of increasing duodenal or midjejunal glucose infusion from 5 to 9 hours on portal blood flow and net portal flux of a-amino N, L-lactate, and oxygen a Standard error of the mean, n = 6 for duodenum, n = 5 for midjejunum. b Site effect ( P < .05). c Site effect ( P < .01). d Quadratic level effect ( P < .05). e Site × level effect ( P < .10). f Site effect ( P < .10). into the duodenum and increased as glucose plus 2DG infusion in the midjejunum increased from 0 to 20 g/h. When 9 and 18 g/h glucose was infused into the duodenum, 99 and 96% of the glucose infused, respectively, disappeared in the small intestine. In contrast, only 56 and 45% of the 9 and 18 g/h glucose infused into the midjejunum, respectively, disappeared in the small intestine. In addition, when glucose plus 2DG was infused into the duodenum at 9 and 18 g/h, net PDV absorption of glucose accounted for 63 and 104%, respectively, of small intestinal glucose disappearance. When glucose plus 2DG was infused into the midjejunum, net portal flux of glucose was negative (i.e., no net portal appearance of glucose occurred). From 5 to 9 h of infusion, arterial concentration of glucose was not affected ( P > .10) by glucose plus 2DG infusion (Table 2) . However, arterial concentration of 2DG was greater (site effect, P < .05) when glucose plus 2DG was infused into the duodenum and increased (linear, P < .001) as glucose plus 2DG infusion in both duodenum and midjejunum increased from 0 to 20 g/h. Portal-arterial concentration difference and net PDV flux of glucose increased (linear, P < .05) as glucose plus 2DG infusion in both duodenum and midjejunum increased from 0 to 20 g/h (Table 2 ). In addition, compared with infusion of glucose plus 2DG into the midjejunum, infusion of glucose plus 2DG into the duodenum resulted in higher (site effect, P < .05) PA difference and net PDV flux of glucose. Portal-arterial concentration difference and net PDV flux of 2DG responded with a site × level interaction ( P < .05). When glucose plus 2DG was infused into the duodenum, PA difference and net PDV flux of 2DG increased. In contrast, when glucose plus 2DG was infused into the midjejunum, PA difference and net PDV flux of 2DG did not differ from zero ( P > .10). Simple linear regression indicated that greater than 100% of the duodenally infused glucose was accounted for in portal blood as glucose (net portal glucose = 1.09 [glucose infused] −4.31; r 2 = .40). In contrast, a similar regression indicated that only 7% of duodenally infused 2DG was accounted for in portal blood as 2DG (net portal 2DG = .07 [2DG infused] + .09; r 2 = .29). A net flux vs glucose infusion slope of greater than 1.0 may suggest that 2DG acted as a metabolic inhibitor, decreasing PDV utilization of glucose.
Portal blood flow was not affected ( P > .10) by level or time of glucose plus 2DG infusion (Table 3) . However, portal blood flow was greater ( P < .05) when glucose plus 2DG was infused into the duodenum. Arterial concentrations of AAN and L-lactate were not affected ( P > .10) by site or level of glucose plus 2DG infusion (Table 3) . Arterial oxygen concentration was similar when 0 and 10 g/h glucose plus 2DG was infused and increased (quadratic, P < .05) when 20 g/h glucose plus 2DG was infused. In addition, arterial oxygen was greater ( P < .01) when glucose plus 2DG was infused into the duodenum than when it was infused into the midjejunum. Portalarterial concentration difference and net portal flux of AAN were not affected ( P > .10) by site or level of glucose plus 2DG infusion. Portal-arterial concentration difference of L-lactate responded with a site × level interaction ( P < .10). Net portal flux of L-lactate was greater ( P < .05) when glucose plus 2DG was infused into the duodenum than when glucose plus 2DG was infused into the midjejunum. Portal-arterial concentration difference of oxygen was not affected ( P > .10) by site or glucose plus 2DG treatment. Net portal flux of oxygen was greater ( P < .10) when glucose plus 2DG was infused into the duodenum, which is similar to the response observed for portal blood flow (Table 3) .
Discussion
As discussed by Kreikemeier et al. (1991) , periods lasting 9 h coupled with feeding chopped alfalfa raises the concern of whether adaptation to glucose transport occurs in the brush border. Recently, Bauer et al. (1995) demonstrated in steers that a 4-d abomasal infusion of a starch hydrolysate increased PDV flux of glucose threefold compared with steers that were not infused. However, steers unadapted to digesting starch maintained the ability to transport at least 7 g/ h of glucose out of the intestinal lumen. In addition, infusing glucose (30 mM) for 4 d into the duodenum of sheep increased the rate of Na + -dependent glucose transport close to levels in the pre-ruminant state (Shirazi-Beechey et al., 1991) . These experiments suggest that luminal glucose increases active glucose transport in ruminants. Therefore, conclusions drawn from our experiment are based on the short-term (i.e., acute) effects of small intestinal glucose infusion on glucose absorption. The rise and plateau in PA difference and net PDV flux of glucose when glucose plus 2DG was infused into the duodenum (data not shown) suggests that steady-state conditions were achieved before our 5-to 9-h sampling window.
Abomasal infusion of increasing levels of glucose generally results in an increase in arterial concentrations of glucose (Huntington and Reynolds, 1986; Kreikemeier et al., 1991; Kreikemeier and Harmon, 1995) . In contrast, increasing glucose plus 2DG infusion into the duodenum did not increase arterial concentration of glucose, although arterial concentration of 2DG did increase in our experiment. This discrepancy may be due to the lower levels of glucose infusion in our experiment compared with previous experiments (Huntington and Reynolds, 1986; Kreikemeier et al., 1991; Kreikemeier and Harmon, 1995) , although Kreikemeier et al. (1991) reported an increase in arterial glucose when 20 g/h of glucose was infused. An alternative explanation may be that 2DG, which is phosphorylated by glucokinase but is not further metabolized (Brun et al., 1993) , inhibits glycolysis in cells in peripheral tissues. Therefore, peripheral tissues may take up more glucose to compensate for this inhibition. In addition, infusion of increasing glucose plus 2DG into the duodenum resulted in an increase in arterial concentration of insulin in our experiment (data not shown). This increase in insulin may also explain the lack of an increase in arterial glucose. The increase in arterial insulin concentration without an increase in net PDV flux of insulin suggests that peripheral clearance of insulin was decreased when increasing glucose plus 2DG was infused into the duodenum.
In addition to active transport of glucose by SGLT1, passive diffusion of glucose across the brush border membrane of the small intestine may occur (White et al., 1971; Kreikemeier et al., 1991) . Kreikemeier et al. (1991) infused 0 to 60 g/h of glucose into the abomasum in steers. Glucose flowing past the ileum increased with increasing glucose infusion, suggesting that active transport of glucose was saturated at the higher levels of infusion (40 and 60 g/h). The fact that net portal glucose appearance continually rose with increased glucose infusion suggests that passive diffusion of glucose across the small intestine may have predominated when 40 and 60 g/h of glucose was infused. In our experiment, 2DG was used to estimate passive diffusion of glucose. Although small intestinal disappearance of 2DG was not determined, appearance of 2DG in portal blood accounted for only 9.5 and 6.7% of the 1 and 2 g/h, respectively, of 2DG infused when 2DG was infused into the duodenum. Because 10% of the total glucose plus 2DG infusion was 2DG, maximum diffusion of glucose may be estimated as 2DG diffusion × 10, if 2DG behaves as an ideal marker for glucose. Therefore, when glucose plus 2DG was infused into the duodenum at 20 g/h, diffusion of glucose into portal blood was only 1.34 g/h, or 7.4% of the glucose infused. These data suggest that passive diffusion of glucose is a minor route of glucose absorption. As suggested by Kreikemeier et al. (1991) , passive diffusion of glucose may increase as glucose concentration in the small intestine increases, and exceeds the capacity for active glucose transport via SGLT1. However, in our experiment the amount of 2DG that could be accounted for in portal blood decreased as 2DG infusion increased from 1 to 2 g/h.
It has been estimated that 4 to 12% of infused carbohydrate passing the ileum is in the form of unpolymerized glucose when starch is infused into the abomasum of cattle or sheep (Mayes and Ørskov, 1974; Kreikemeier et al., 1991; Kreikemeier and Harmon, 1995) . This indicates that complete starch hydrolysis occurs at a faster rate than active transport of glucose across the small intestine. This phenomenon, coupled with estimates of only 26 to 57% net portal glucose absorption when starch is infused abomasally (Huntington and Reynolds, 1986; Kreikemeier et al., 1991; Kreikemeier and Harmon, 1995) , may indicate that small intestinal starch digestion occurs at a site that exceeds the capacity for glucose absorption. In cattle, Russell (1979) determined that only 7% of the alpha-glucosides had been digested at 40% of the small intestinal length when up to 2,000 g of starch was infused abomasally. White et al. (1971) studied rates of disappearance of glucose from ligated loops of small intestine in lambs, adult sheep, and young rats. They reported that rate of absorption of glucose decreased along the intestine from the duodenum to the ileum in lambs and rats. The decreased absorption rate also occurred in adult sheep, but to a lesser extent. In our experiment, disappearance of glucose in the small intestine was 96 and 45% when 18 g/h of glucose was infused into the duodenum or midjejunum, respectively (Table 2 ). This indicates that glucose disappearance is similar across the two sites because the distance from the midjejunum to the ileum is approximately one-half of the distance from the duodenum to the ileum. However, it should be noted that all of the glucose infused into the duodenum could have been absorbed prior to the midjejunum.
In our experiment, net portal absorption of glucose could account for 104% of the small intestinal glucose disappearance when 18 g/h of glucose was infused duodenally, which is similar to the 100% found by Kreikemeier et al. (1991) when 20 g/h of glucose was infused abomasally. Alternatively, infusing 18 g/h of glucose into the midjejunum resulted in a net utilization of glucose and no net appearance occurred. Calculating net PDV glucose flux by subtracting glucose flux during water infusion (Kreikemeier and Harmon, 1995) resulted in a net portal glucose flux of 11.4 and 23.9 g/h when 9 and 18 g/h, respectively, of glucose was infused into the duodenum, and 1.6 and 4.7 g/h when 9 and 18 g/h of glucose was infused into the midjejunum. This resulted in net portal glucose absorption accounting for 32 and 58% of the small intestinal glucose disappearance when 9 and 18 g/h of glucose was infused into the midjejunum, which is much lower than the 128 and 138% recovery when glucose was infused into the duodenum. The greater net portal glucose flux when glucose was infused into the duodenum coincides with a greater amount of glucose disappearing from the small intestine. This indicates that glucose was more readily absorbed across the proximal-vs the distal-half of the small intestine. This response is supported by data that showed that SGLT1 mRNA is lower in the distal (75% of length) small intestine than in the proximal (25% of length) and mid (50% of length) small intestine in weaned lambs (Freeman et al., 1993) . In addition, it seems from our data that passive diffusion of glucose is lower in the distal segment of the small intestine because no net PDV absorption of 2DG occurred when glucose plus 2DG was infused into the midjejunum (Table 2) . Therefore, if starch is hydrolyzed closer to the mid-point of the small intestine, it seems that glucose absorption could limit starch utilization in ruminants.
In our experiment, when 18 g/h of glucose was infused into the midjejunum, small intestinal glucose disappearance accounted for 45% of glucose infused (Table 2 ). Others have shown that when starch is infused abomasally, recovery of starch as net portal glucose absorption is incomplete, ranging from 26 to 57% (Huntington and Reynolds, 1986; Kreikemeier et al., 1991; Kreikemeier and Harmon, 1995) . Glucose hydrolyzed from starch in the distal small intestine may be available for microbial fermentation. Therefore, the activity of microbes present in the small intestine may play an important role in intestinal glucose disappearance. Armstrong and Beever (1969) reported that small quantities of cellulose disappeared from the small intestine, although enzymes capable of cleaving the b-1,4 glycosidic linkage are not produced by the host animal. Their results indicate that microbial fermentation does occur in the small intestine. Kreikemeier et al. (1991) showed that increasing abomasal infusion of starch from 0 to 60 g/h decreased ileal pH from 7.89 to 7.56, respectively. In our experiment, increasing midjejunal infusions of glucose from 0 to 18 g/h numerically decreased ileal pH from 7.78 to 7.64, although total VFA concentration was greater when glucose was infused into the duodenum rather than the midjejunum (Table 1) . Nicoletti et al. (1984) examined microflora of the small intestine of sheep and found bacteria at 10 6 cells/g of digesta. All bacteria isolated from the small intestine were able to utilize starch, the major end products of in vitro fermentation being lactic, acetic, and formic acids. Whether the population of 10 6 organisms/g of small intestinal digesta shown in the study of Nicoletti et al. (1984) is large enough to compete for starch escaping ruminal digestion is uncertain.
Small intestinal glucose may also be absorbed into the brush border and used as a fuel by small intestinal mucosa or converted to mesenteric fat. Janes et al. (1985) estimated that 41 to 44% of lactate produced by intestinal tissues was derived from the metabolism of glucose in sheep. However, the major portion of glucose utilized was derived from the arterial glucose supply. In our experiment, PA difference and net portal flux of L-lactate was greater ( P < .05) when glucose was infused into the duodenum rather than the midjejunum, although there was no effect of increasing glucose level.
Implications
Because the efficiency of energy utilization may be greater if glucose is absorbed from the small intestine rather than being fermented in the rumen, understanding limitations to small intestinal starch digestion and subsequent glucose absorption is warranted. Enhancing ruminal starch escape without corresponding digestion in the proximal small intestine would be unlikely to enhance glucose availability because of the lower absorptive capacity in the distal small intestine.
